TETRACYCLINE HYDROCHLORIDE vs TIGECYCLINE

Compare TETRACYCLINE HYDROCHLORIDE (Tetracycline Hydrochloride) and TIGECYCLINE (Tigecycline) — clinical data, side effects, and patient experiences.

TETRACYCLINE HYDROCHLORIDE

Tetracycline Hydrochloride · Tetracycline Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

Streptococcus pneumoniae

Mycoplasma pneumoniae (Eaton agent

OralTablet

TIGECYCLINE

Tigecycline · Tetracycline Antibiotic

How it works

12.1 Mechanism of Action Tigecycline is a tetracycline class antibacterial [see Microbiology ( 12.4 )] .

Approved for

including ventilator-associated pneumonia ( 1.4 ). To reduce the development of drug-resistant bacteria and maintain the effectiveness of tigecycline for injection and other antibacterial drugs

Enterococcus faecalis (vancomycin-susceptible isolates)

Staphylococcus aureus (methicillin-susceptible and -resistant isolates)

Streptococcus agalactiae

IntravenousTablet

Quick Comparison

TETRACYCLINE HYDROCHLORIDETIGECYCLINE

Drug Class

Tetracycline Antibiotic

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TETRACYCLINE HYDROCHLORIDE

Nausea

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

Joint Pain

1-10%

Fatigue

1-10%

TIGECYCLINE

Drug Not Working

>10%

Nausea

1-10%

Vomiting

1-10%

Diarrhea

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

TETRACYCLINE HYDROCHLORIDE

WARNINGS Tooth Development The use of drugs of the tetracycline-class during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown)
Tetracycline drugs should not be used in this age group, except for anthrax, unless other drugs are not likely to be effective or are contraindicated
Clostridium difficile Associated Diarrhea Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including tetracyclines, and may range in severity from mild diarrhea to fatal colitis
Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH

TIGECYCLINE

5 WARNINGS AND PRECAUTIONS All-Cause Mortality: A meta-analysis of Phase 3 and 4 clinical trials demonstrated an increase in all-cause mortality in tigecycline-treated patients compared to controls with a risk difference of 0
Patients who develop abnormal liver function tests during tigecycline for injection therapy should be monitored for evidence of worsening hepatic function and evaluated for risk/benefit of continuing tigecycline therapy
4 ) Pancreatitis: including fatalities, has been reported with tigecycline for injection
In all 13 Phase 3 and 4 trials that included a comparator, death occurred in 4% (150/3,788) of patients receiving tigecycline for injection and 3% (110/3,646) of patients receiving comparator drugs

Clinical Trial Data

No head-to-head clinical studies found for TETRACYCLINE HYDROCHLORIDE vs TIGECYCLINE.

TETRACYCLINE HYDROCHLORIDE vs TIGECYCLINE: What You Should Know

Key Differences

Both TETRACYCLINE HYDROCHLORIDE and TIGECYCLINE belong to the Tetracycline Antibiotic class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. TETRACYCLINE HYDROCHLORIDE is administered via Oral, whereas TIGECYCLINE uses Intravenous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

TETRACYCLINE HYDROCHLORIDE carries 4 FDA warnings. TIGECYCLINE carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

DOXYCYCLINE MONOHYDRATE vs TIGECYCLINE→OMADACYCLINE vs TIGECYCLINE→DOXYCYCLINE MONOHYDRATE vs TETRACYCLINE HYDROCHLORIDE→DOXYCYCLINE vs TIGECYCLINE→DOXYCYCLINE HYCLATE vs TIGECYCLINE→MINOCYCLINE HYDROCHLORIDE vs TIGECYCLINE→

Loading comparison data...

TETRACYCLINE HYDROCHLORIDE vs TIGECYCLINE

Compare TETRACYCLINE HYDROCHLORIDE (Tetracycline Hydrochloride) and TIGECYCLINE (Tigecycline) — clinical data, side effects, and patient experiences.

TETRACYCLINE HYDROCHLORIDE

Tetracycline Hydrochloride · Tetracycline Antibiotic

How it works

Other agent

Approved for

INDICATIONS AND USAGE To reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs

they should be considered in selecting or modifying antibacterial therapy. In the absence of such data

Streptococcus pneumoniae

Mycoplasma pneumoniae (Eaton agent

OralTablet

TIGECYCLINE

Tigecycline · Tetracycline Antibiotic

How it works

12.1 Mechanism of Action Tigecycline is a tetracycline class antibacterial [see Microbiology ( 12.4 )] .

Approved for

including ventilator-associated pneumonia ( 1.4 ). To reduce the development of drug-resistant bacteria and maintain the effectiveness of tigecycline for injection and other antibacterial drugs

Enterococcus faecalis (vancomycin-susceptible isolates)

Staphylococcus aureus (methicillin-susceptible and -resistant isolates)

Streptococcus agalactiae

IntravenousTablet

Quick Comparison

TETRACYCLINE HYDROCHLORIDETIGECYCLINE

Drug Class

Tetracycline Antibiotic

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

TETRACYCLINE HYDROCHLORIDE

Nausea

1-10%

Diarrhea

1-10%

Vomiting

1-10%

Headache

1-10%

Dizziness

1-10%

Weakness

1-10%

Joint Pain

1-10%

Fatigue

1-10%

TIGECYCLINE

Drug Not Working

>10%

Nausea

1-10%

Vomiting

1-10%

Diarrhea

0.1-1%

Condition Worsened

0.1-1%

FDA Warnings

TETRACYCLINE HYDROCHLORIDE

WARNINGS Tooth Development The use of drugs of the tetracycline-class during tooth development (last half of pregnancy, infancy and childhood to the age of 8 years) may cause permanent discoloration of the teeth (yellow-gray-brown)
Tetracycline drugs should not be used in this age group, except for anthrax, unless other drugs are not likely to be effective or are contraindicated
Clostridium difficile Associated Diarrhea Clostridium difficile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including tetracyclines, and may range in severity from mild diarrhea to fatal colitis
Women of childbearing age who are overweight or have a history of IH are at greater risk for developing tetracycline associated IH

TIGECYCLINE

5 WARNINGS AND PRECAUTIONS All-Cause Mortality: A meta-analysis of Phase 3 and 4 clinical trials demonstrated an increase in all-cause mortality in tigecycline-treated patients compared to controls with a risk difference of 0
Patients who develop abnormal liver function tests during tigecycline for injection therapy should be monitored for evidence of worsening hepatic function and evaluated for risk/benefit of continuing tigecycline therapy
4 ) Pancreatitis: including fatalities, has been reported with tigecycline for injection
In all 13 Phase 3 and 4 trials that included a comparator, death occurred in 4% (150/3,788) of patients receiving tigecycline for injection and 3% (110/3,646) of patients receiving comparator drugs

Clinical Trial Data

No head-to-head clinical studies found for TETRACYCLINE HYDROCHLORIDE vs TIGECYCLINE.

TETRACYCLINE HYDROCHLORIDE vs TIGECYCLINE: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.